Vascular tissue engineering: Biodegradable scaffold platforms to promote angiogenesis

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Serbo, Janna V ^a   Gerecht, Sharon ^b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; BIODEGRADABLE SCAFFOLD; BIOMATERIAL; COLLAGEN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 9; GLYCOSAMINOGLYCAN; PLATELET DERIVED GROWTH FACTOR; POLYESTER; POLYMER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT STEM CELL; ANGIOGENESIS; ARTICLE; BIOCOMPATIBILITY; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL HOMING; EXTRACELLULAR MATRIX; FORCE; HOMEOSTASIS; HUMAN; MECHANICAL FORCE; NONHUMAN; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGENERATIVE MEDICINE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOMATIC CELL; TISSUE ENGINEERING; TISSUE REGENERATION; VASCULAR TISSUE; ANIMAL; BIODEGRADABLE IMPLANT; BLOOD VESSEL; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; ANIMALS; BLOOD VESSELS; CELL DIFFERENTIATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84873030339     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt156     Document Type: Article

References (74)

1. Tissue-engineered blood vessels: alternative to autologous grafts? Hoenig MR, Arterioscler Thromb Vasc Biol 2005 25 1128 1134 10.1161/01.ATV.0000158996. 03867.72 15705929 (Pubitemid 40776598)
2. Vascularization shaping the heart. Lesman A, Gepstein L, Levenberg S, Ann N Y Acad Sci 2010 1188 46 51 10.1111/j.1749-6632.2009.05082.x 20201885
3. Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease. Dean EW, Udelsman B, Breuer CK, Yale J Biol Med 2012 85 229 238 22737051
4. Deaths: preliminary data for 2010. Murphy SL, Xu J, Kochanek KD, Natl Vital Stat Rep 2012 60 1 52 22970648
5. World Health Organization, The Global Burden of Disease: 2004 Update Geneva: WHO Press 2008
6. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ, Circulation 2011 123 933 944 10.1161/CIR.0b013e31820a55f5 21262990
7. Readily available tissue-engineered vascular grafts. Dahl SLM, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE, Sci Transl Med 2011 3 68ra69
8. Blood vessels engineered from human cells. Gong Z, Niklason LE, Trends Cardiovasc Med 2006 16 153 156 10.1016/j.tcm.2006.02.006 16781948 (Pubitemid 43867328)
9. Tissue engineering of blood vessel. Zhang WJ, Liu W, Cui L, Cao Y, J Cell Mol Med 2007 11 945 957 10.1111/j.1582-4934.2007.00099.x 17979876 (Pubitemid 350041636)
10. Molecular mechanisms and clinical applications of angiogenesis. Carmeliet P, Jain RK, Nature 2011 473 298 307 10.1038/nature10144 21593862
11. Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Yoder MC, Ingram DA, Curr Opin Hematol 2009 16 269 273 10.1097/MOH.0b013e32832bbcab 19417649
12. Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. Ingber DE, Folkman J, J Cell Biol 1989 109 317 330 10.1083/jcb.109.1. 317 2473081 (Pubitemid 19180139)
13. Regulation of angiogenesis: apoptotic cues from the ECM. Cheresh DA, Stupack DG, Oncogene 2008 27 6285 6298 10.1038/onc.2008.304 18931694
14. The development of the vasculature and its extracellular matrix: a gradual process defined by sequential cellular and matrix remodeling events. Davis GE, Am J Physiol Heart Circ Physiol 2010 299 245 H247 10.1152/ajpheart. 00525.2010 20543090
15. Mechanisms controlling human endothelial lumen formation and tube assembly in three-dimensional extracellular matrices. Davis GE, Koh W, Stratman AN, Birth Defects Res C Embryo Today 2007 81 270 285 10.1002/bdrc.20107 18228260 (Pubitemid 351186175)
16. Distinct ECM mechanosensing pathways regulate microtubule dynamics to control endothelial cell branching morphogenesis. Myers KA, Applegate KT, Danuser G, Fischer RS, Waterman CM, J Cell Biol 2011 192 321 334 10.1083/jcb.201006009 21263030
17. Endothelial cell adhesion, signaling, and morphogenesis in fibroblast-derived matrix. Soucy PA, Romer LH, Matrix Biol 2009 28 273 283 10.1016/j.matbio.2009.04.005 19375504
18. In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Shin Y, Jeon JS, Han S, Jung G-S, Shin S, Lee S-H, Sudo R, Kamm RD, Chung S, Lab Chip 2011 11 2175 10.1039/c1lc20039a 21617793
19. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. des Rieux A, Ucakar B, Mupendwa BPK, Colau D, Feron O, Carmeliet P, Préat V, J Control Release 2011 150 272 278 10.1016/j.jconrel.2010.11. 028 21130820
20. Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Frontini MJ, Nong Z, Gros R, Drangova M, O'Neil C, Rahman MN, Akawi O, Yin H, Ellis CG, Pickering JG, Nat Biotechnol 2011 29 421 427 10.1038/nbt.1845 21499246
21. Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tengood JE, Ridenour R, Brodsky R, Russell AJ, Little SR, Tissue Eng Part A 2011 17 1181 1189 10.1089/ten.tea.2010.0551 21142700
22. Research highlights. Barreto-Ortiz SF, Gerecht S, Regen Med 2011 6 551 554 10.2217/rme.11.53 21916590
23. The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. Singh S, Wu BM, Dunn JCY, Biomaterials 2011 32 2059 2069 10.1016/j.biomaterials.2010.11.038 21147501
24. Accelerating vascularization in polycaprolactone scaffolds by endothelial progenitor cells. Singh S, Wu BM, Dunn JCY, Tissue Eng Part A 2011 17 1819 1830 10.1089/ten.tea.2010.0708 21395445
25. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Stratman AN, Davis MJ, Davis GE, Blood 2011 117 3709 3719 10.1182/blood-2010-11-316752 21239704
26. Vascular endothelial growth factors and angiogenesis in eye disease. Witmer AN, Vrensen GF, Van Noorden CJ, Schlinemann RO, Prog Retin Eye Res 2003 22 1 29 10.1016/S1350-9462(02)00043-5 12597922 (Pubitemid 36207453)
27. The effect of physical exercise on endothelial function. Di Francescomarino S, Sciartilli A, Di Valerio V, Di Baldassarre A, Gallina S, Sports Med 2009 39 797 812 10.2165/11317750-000000000-00000 19757859
28. Role of shear stress and stretch in vascular mechanobiology. Lu D, Kassab GS, J R Soc Interface 2011 8 1379 1385 10.1098/rsif.2011.0177 21733876
29. Nanotechnological strategies for engineering complex tissues. Dvir T, Timko BP, Kohane DS, Langer R, Nat Nanotechnol 2011 6 13 22 21151110
30. Stem cell sources for vascular tissue engineering and regeneration. Bajpai VK, Andreadis ST, Tissue Eng Part B Rev 2012 5 405 425
31. Stem cell derived endothelial cells for cardiovascular disease; a therapeutic perspective. Reed DM, Foldes G, Harding SE, Mitchell JA, Br J Clin Pharmacol 2012
32. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA, Blood 2007 109 1801 1809 10.1182/blood-2006-08-043471 17053059 (Pubitemid 46348173)
33. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK, Blood 2007 111 1302 1305 10.1182/blood-2007-06-094318 17993613
34. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Joachim O, Sabine B, Birgitte J, Silvia F, Gerhard E, Martin B, Carsten W, Stem Cells 2004 22 377 384 10.1634/stemcells.22-3-377 15153614
35. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Kinner B, Zaleskas JM, Spector M, Exp Cell Res 2002 278 72 83 10.1006/excr.2002.5561 12126959 (Pubitemid 34775447)
36. Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Dong JD, Gu YQ, Li CM, Wang CR, Feng ZG, Qiu RX, Chen B, Li JX, Zhang SW, Wang ZG, Zhang J, Acta Pharmacol Sin 2009 30 530 536 10.1038/aps.2009.40 19417732
37. Regeneration of smooth muscle cells from bone marrow: use of mesenchymal stem cells for tissue engineering and cellular therapeutics. Nan W, Linlin M, Zhen Z, Junyun Z, Xuegang L, Yong J, Tongcun Z, 3rd International Conference on Bioinformatics and Biomedical Engineering, iCBBE 2009: 2009 Beijing, China 2009
38. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. Hirschi KK, Rohovsky SA, D'Amore PA, J Cell Biol 1998 141 805 814 10.1083/jcb.141.3.805 9566978 (Pubitemid 28217923)
39. Direct cell contact influences bone marrow mesenchymal stem cell fate. Ball SG, Shuttleworth AC, Kielty CM, Int J Biochem Cell Biol 2004 36 714 727 10.1016/j.biocel.2003.10.015 15010334 (Pubitemid 38316826)
40. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 861 872 10.1016/j.cell.2007.11.019 18035408 (Pubitemid 350138099)
41. Embryonic stem cell lines derived from human blastocysts. Thomson JA, Science 1998 282 1145 1147 9804556 (Pubitemid 28516247)
42. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Choi K-D, Junying Y, Kim S-O, Giorgia S, William R, Maxim V, James T, Igor S, Stem Cells 2009 27 559 567 19259936
43. Hematoendothelial differentiation of human embryonic stem cells. Vodyanik MA, Slukvin II, Current Protoc Cell Biol 2007 Chapter 23 nit 23.6
44. Endothelial cells derived from human embryonic stem cells. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R, Proc Natl Acad Sci USA 2002 99 4391 4396 10.1073/pnas.032074999 11917100 (Pubitemid 34285995)
45. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Kaufman DS, Lewis RL, Hanson ET, Auerbach R, Plendl J, Thomson JA, Blood 2004 103 1325 1332 14563647 (Pubitemid 38168644)
46. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G, Proc Natl Acad Sci USA 2007 104 11298 11303 10.1073/pnas.0703723104 17581871 (Pubitemid 47175135)
47. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle-like cells and form vascular networks in vivo. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, Dallabrida SM, Vunjak-Novakovic G, Langer R, Circ Res 2007 101 286 294 10.1161/CIRCRESAHA.107. 150201 17569886 (Pubitemid 47344078)
48. Vascular gene expression and phenotypic correlation during differentiation of human embryonic stem cells. Gerecht-Nir S, Dazard JE, Golan-Mashiach M, Osenberg S, Botvinnik A, Amariglio N, Domany E, Rechavi G, Givol D, Itskovitz-Eldor J, Dev Dyn 2005 232 487 497 10.1002/dvdy.20247 15614775 (Pubitemid 40129802)
49. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Gerecht-Nir S, Ziskind A, Cohen S, Itskovitz-Eldor J, Lab Invest 2003 83 1811 1820 10.1097/01.LAB.0000106502.41391.F0 14691299 (Pubitemid 38018544)
50. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Wang L, Li L, Shojaei F, Levac K, Cerdan C, Menendez P, Martin T, Rouleau A, Bhatia M, Immunity 2004 21 31 41 10.1016/j.immuni.2004.06.006 15345218 (Pubitemid 38925265)
51. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H, Arzigian M, Fukumura D, Jain RK, Scadden DT, Nat Biotechnol 2007 25 317 318 10.1038/nbt1287 17322871 (Pubitemid 46398769)
52. VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering. Nourse M B, Halpin DE, Scatena M, Mortisen DJ, Tulloch NL, Hauch KD, Torok-Storb B, Ratner BD, Pabon L, Murry CE, Arterioscler Thromb Vasc Biol 30 80 89
53. Neuropilin-1 identifies endothelial precursors in human and murine embryonic stem cells before CD34 expression. Cimato T, Beers J, Ding S, Ma M, McCoy JP, Boehm M, Nabel EG, Circulation 2009 119 2170 2178 10.1161/ CIRCULATIONAHA.109.849596 19364973
54. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhibition is Id1 dependent. James D, Nam HS, Seandel M, Nolan D, Janovitz T, Tomishima M, Studer L, Lee G, Lyden D, Benezra R, Zaninovic N, Rosenwaks Z, Rabbany SY, Rafii S, Nat Biotechnol 2010 28 161 166 10.1038/nbt.1605 20081865
55. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Sone M, Itoh H, Yamahara K, Yamashita JK, Yurugi-Kobayashi T, Nonoguchi A, Suzuki Y, Chao TH, Sawada N, Fukunaga Y, Miyashita K, Park K, Oyamada N, Sawada N, Taura D, Tamura N, Kondo Y, Nito S, Suemori H, Nakatsuji N, Nishikawa S, Nakao K, Arterioscler Thromb Vasc Biol 2007 27 2127 2134 10.1161/ATVBAHA.107.143149 17872458 (Pubitemid 350287240)
56. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K, Arterioscler Thromb Vasc Biol 2009 29 1100 1103 10.1161/ATVBAHA.108.182162 19423866
57. The enhancement of endothelial cell therapy for angiogenesis in hindlimb ischemia using hyaluronan. Tang ZCW, Liao W-Y, Tang ACL, Tsai S-J, Hsieh PCH, Biomaterials 2011 32 75 86 10.1016/j.biomaterials.2010.08.085 20889204
58. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Singelyn JM, DeQuach JA, Seif-Naraghi SB, Littlefield RB, Schup-Magoffin PJ, Christman KL, Biomaterials 2009 30 5409 5416 10.1016/j.biomaterials.2009.06.045 19608268
59. Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres. Mima Y, Fukumoto S, Koyama H, Okada M, Tanaka S, Shoji T, Emoto M, Furuzono T, Nishizawa Y, Inaba M, PLoS ONE 2012 7 35199 10.1371/journal.pone.0035199 22529991
60. Injectable scaffolds for tissue regeneration. Hou QP, De Bank PA, Shakesheff KM, J Mater Chem 2004 14 1915 1923 10.1039/b401791a
61. Engineering vessel-like networks within multicellular fibrin-based constructs. Lesman A, Koffler J, Atlas R, Blinder YJ, Kam Z, Levenberg S, Biomaterials 2011 32 7856 7869 10.1016/j.biomaterials.2011.07.003 21816465
62. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Hanjaya-Putra D, Bose V, Shen YI, Yee J, Khetan S, Fox-Talbot K, Steenbergen C, Burdick JA, Gerecht S, Blood 2011 118 804 815 10.1182/blood-2010-12-327338 21527523
63. Tissue-engineered lungs for in vivo implantation. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, Raredon MB, Gavrilov K, Yi T, Zhuang ZW, Breuer C, Herzog E, Niklason LE, Science 2010 329 538 541 10.1126/science.1189345 20576850
64. Bioengineering in organ transplantation: targeting the liver. Fukumitsu K, Yagi H, Soto-Gutierrez A, Transplant Proc 2011 43 2137 2138 10.1016/j.transproceed.2011.05.014 21839215
65. Strategies for tissue and organ decellularization. Gilbert TW, J Cell Biochem 2012 113 2217 2222 10.1002/jcb.24130 22415903
66. Organ engineering based on decellularized matrix scaffolds. Song JJ, Ott HC, Trends Mol Med 2011 17 424 432 10.1016/j.molmed.2011.03.005 21514224
67. Engineering vascularized skeletal muscle tissue. Levenberg S, Rouwkema J, Macdonald M, Garfein ES, Kohane DS, Darland DC, Marini R, van Blitterswijk CA, Mulligan RC, D'Amore PA, Langer R, Nat Biotechnol 2005 23 879 884 10.1038/nbt1109 15965465 (Pubitemid 43093132)
68. Transplantation of a tissue-engineered human vascularized cardiac muscle. Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S, Gepstein L, Tissue Eng Part A 2010 16 115 125 19642856
69. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Caspi O, Lesman A, Basevitch Y, Gepstein A, Arbel G, Habib IH, Gepstein L, Levenberg S, Circ Res 2007 100 263 272 10.1161/01.RES.0000257776. 05673.ff 17218605 (Pubitemid 46208727)
70. Functional groups affect physical and biological properties of dextran-based hydrogels. Sun G, Shen Y-I, Ho CC, Kusuma S, Gerecht S, J Biomed Mater Res A 2010 93 1080 1090 19753626
71. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Sun G, Shen Y-I, Kusuma S, Fox-Talbot K, Steenbergen CJ, Gerecht S, Biomaterials 2011 32 95 106 10.1016/j.biomaterials. 2010.08.091 20870284
72. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Sun G, Zhang X, Shen YI, Sebastian R, Dickinson LE, Fox-Talbot K, Reinblatt M, Steenbergen C, Harmon JW, Gerecht S, Proc Natl Acad Sci USA 2011 108 20976 20981 10.1073/pnas.1115973108 22171002
73. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Koffler J, Kaufman-Francis K, Shandalov Y, Egozi D, Pavlov DA, Landesberg A, Levenberg S, Proc Natl Acad Sci USA 2011 108 14789 14794 10.1073/pnas.1017825108 21878567
74. Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM, Fukumura D, Scadden DT, Jain RK, Blood 2008 111 1302 1305 17993613 (Pubitemid 351213415)